Fractyl Health, Inc. - Common Stock (NQ:GUTS)

0.9970 +0.1070 (+12.02%)

Delayed Quote Updated: 1:07 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fractyl Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones

December 15, 2025

Holders will have until December 30, 2025 to exercise Tranche A Warrants at $1.05 per share, enabling up to $17.9 million in potential gross proceeds

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health's Revita Procedure Helps Patients Keep Weight Off After Stopping GLP-1 Drugs ↗

December 02, 2025

Fractyl Health (NASDAQ: GUTS) released positive 6-month results from its REVEAL-1 study in obese patients who discontinued GLP-1 therapy.

Via Benzinga

Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

December 02, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

GUTS Stock Rallied About 28% Today – Here’s Why ↗

September 26, 2025

Via Stocktwits

An Overview of Fractyl Health's Earnings ↗

August 11, 2025

Via Benzinga

Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference

December 01, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl (GUTS) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Fractyl (GUTS) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Fractyl Health Reports Third Quarter 2025 Results; Revita® Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027

November 12, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Preview: Fractyl Health's Earnings ↗

November 11, 2025

Via Benzinga

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

November 05, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity

October 07, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Unusual volume stocks are being observed in Wednesday's session. ↗

October 01, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

MAGA Stocks Undercard: SNYR GUTS MRM MYSE Under $3 To Watch Now….more inside

September 26, 2025

Via AB Newswire

Topics Economy

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 26, 2025

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.

Via Benzinga

What's going on in today's pre-market session ↗

September 26, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 26, 2025

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.

Via Benzinga

Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock

September 26, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation

September 26, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

This Broadcom Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

September 15, 2025

Via Benzinga

Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth

September 03, 2025

Appointments include Christopher Thompson, M.D. and Ian Sheffield as Independent Directors

From Fractyl Health, Inc.

Via GlobeNewswire

This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

August 28, 2025

Via Benzinga

Fractyl Health Posts 62% Wider Q2 Loss ↗

August 12, 2025

Via The Motley Fool

FRACTYL HEALTH INC (NASDAQ:GUTS) Reports Wider-Than-Expected Q2 2025 Loss Amid Clinical Progress ↗

August 12, 2025

Fractyl Health reports Q2 2025 net loss of $27.9M, missing EPS estimates. No revenue, but clinical progress in Revita and Rejuva programs. Stock dips amid investor concerns.

Via Chartmill

Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates

August 12, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

August 07, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference

August 06, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

What's going on in today's session ↗

August 06, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Nasdaq Surges 1%; Uber Sales Top Estimates ↗

August 06, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.